Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy

Benutzer: Gast

Titel:: Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy
Dokumenttyp:: Zeitschriftenaufsatz
Autor(en):: Goetze, Thorsten Oliver ; Stein, Alexander ; Lorenzen, Sylvie ; Habibzada, Timorshah ; Goekkurt, Eray ; Herhaus, Peter ; Loose, Maria ; Sookthai, Disorn ; Brulin, Tanita ; Ihrig, Kristina ; Pauligk, Claudia ; Al-Batran, Salah-Eddin
Stichworte:: SHORT REPORT ; metastatic esophagogastric adenocarcinoma ; ramucirumab ; TAS-102 ; treatment beyond progression
Zeitschriftentitel:: International Journal of Cancer
Jahr:: 2023
Band / Volume:: 153
Heft / Issue:: 10
Seitenangaben Beitrag:: 1726-1733
Volltext / DOI:: doi:10.1002/ijc.34652
Verlag / Institution:: John Wiley & Sons, Inc.
E-ISSN:: 0020-7136 ; 1097-0215
Publikationsdatum:: 16.07.2023
BibTeX

Vorkommen: